Nicholas McGregor

6505--Request for Infromation - U.S. Produced Pharmaceuticals

The U.S. Department of Veterans Affairs is conducting market research through a Request for Information to identify potential sources of U.S.-produced pharmaceuticals in alignment with Executive Order 13944, which emphasizes securing domestic supply chains for essential medicines and medical countermeasures. The VA seeks information on pharmaceuticals that meet the strict definition of U.S.-produced: where critical inputs are manufactured in the United States and the finished drug product is fully manufactured, prepared, propagated, compounded, or processed within the U.S. as defined by federal law. The request specifically targets products listed in Attachment 1, including high-volume injectables such as Dexamethasone Sodium Phosphate, Fentanyl Citrate, Heparin Sodium, and Hydromorphone HCI, with estimated annual quantities provided for market assessment. Respondents must disclose the country of origin for all ingredients and components to allow validation of compliance with EO 13944, and are encouraged to indicate any domestic manufacturing activity, even if not fully U.S.-produced, as such contributions are still of significant value to the VA’s supply resilience goals. All responses must be submitted via a provided spreadsheet with detailed comments on product availability and market conditions, and must include a unique eleven-digit NDC number with the labeler code identifying the respondent as the official labeler, ensuring no labeling conflicts or over-labeling occurs. The VA intends for any resulting contract to have a one-year base period with four one-year option periods to ensure long-term consistency of supply. To qualify, respondents must confirm they have or can obtain a unique NDC for each product and either manufacture the product themselves or provide a binding letter of commitment from the manufacturer guaranteeing supply sufficient to meet government needs, including maintaining at least six months of stock per product. Contractors must also have active chargeback agreements in place with the Pharmaceutical Prime Vendor Program, which handles all VA and Department of Defense pharmaceutical procurement. Companies must indicate their size under NAICS code 325412 and, if small, whether they perform at least 50% of the manufacturing processes. Responses must be submitted by June 24, 2026, and must confirm the ability to begin delivery within 60 days of contract award. This RFI is for planning purposes only and does not constitute a solicitation or guarantee of future procurement, but serves to shape potential future acquisition strategies aimed at reducing supply chain vulnerabilities and ensuring reliable access to critical medications for veterans.

Department Of Veterans AffairsIL,

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

Posted Jun 10, 2026

36E79726Q0002

Closed

Federal2

6505--Acamprosate CA EC Tablets

The solicitation for Acamprosate CA EC Tablets under solicitation number 36E79726R0021, issued by the Department of Veterans Affairs through its Nac Pharmaceuticals office in Hines, Illinois, seeks commercial pharmaceutical supplies under a Lowest Price Technically Acceptable (LPTA) procurement strategy. The contract requires the delivery of 33,661 bottles of 333mg extended-release tablets per base year, with four one-year option periods of equal volume, all subject to strict pharmaceutical and packaging standards. The product must be manufactured and packaged in compliance with FDA regulations, USP-NF monographs, current Good Manufacturing Practices (cGMP), and the Drug Supply Chain Security Act (DSCSA), including serialization via a two-dimensional GS1 Data Matrix bar code at the lowest saleable package level and a linear GS1-128, HIBCC, or UPC bar code complying with ANSI/ISO/IEC Grade C quality standards on the unit-of-use bottle. Packaging must exclude glass, feature a child-resistant safety cap, accommodate automated dispensing systems, provide sufficient space for VA labeling over the contractor’s label, and ensure machine-readable bar codes are presented in ladder orientation with adequate quiet zones and human-readable NDC adjacent to the barcode. The contract incorporates standard Federal Acquisition Regulation clauses with VA-specific deviations, including restrictions on subcontractor sales, mandatory business ethics and whistleblower protections, prohibitions on restrictive confidentiality agreements, and requirements regarding contractor responsibility, suspension, debarment, and inverted domestic corporations. A VA-specific small business subcontracting plan is mandatory for contracts exceeding $700,000, and contractors must affirm small business status, UEI and CAGE codes, and manufacturer commitment if not the producer. Proposals must be submitted by May 28, 2026, via email in PDF or Word format with a signed SF-1449, and must include NDCs, facility FEI numbers, and compliance with DSCSA and FDA requirements. Evaluation is strictly based on lowest price among technically acceptable offers, with no discussions anticipated, and all items are subject to inspection at the source facility and acceptance at the delivery destination. The government will process payments through the VA Prime Vendor program, and all performance must occur at FDA-registered facilities, with deliveries governed by FOB origin or destination terms as specified in individual orders. No contract value is yet determinable, as pricing data must be provided by offerors.

Department Of Veterans AffairsIL,

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

Posted May 14, 2026

36E79726R0021

Closed

Federal4

6505--Fluticasone/Salmeterol Inh Powder

The Department of Veterans Affairs National Acquisition Center plans to issue a Request for Proposal (RFP) for the procurement of Fluticasone/Salmeterol inhalers to serve multiple federal healthcare entities including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. This solicitation seeks a single responsible contractor to provide continuous supply of the inhalers over a base period of one year with four additional one-year option periods. Distribution will occur through the VA’s and DoD’s Pharmaceutical Prime Vendor Programs. The contract requires that all products bear the contractor’s unique label and National Drug Code (NDC), with individual packaging that includes barcodes and compatibility with automated dispensing systems; glass bottles are not permitted. Stability testing for all offered packaging sizes must be certified by the offerors. The solicitation, identified as 36E79726R0009, will be issued electronically around February 23, 2026, with offers due by March 9, 2026. It falls under NAICS code 325412 and will adhere to FAR Part 12 for commercial item acquisitions. Estimated annual demand includes approximately 317,000 canisters of the 100/50 mcg dosage, 1.48 million canisters of the 250/50 mcg dosage, and over 500,000 canisters of the 500/50 mcg dosage. Interested vendors must monitor SAM.gov for updates and submit timely bids. The contract specialist and primary contact for this procurement is Youlanda Duggar, reachable via email at [email hidden].

Department Of Veterans AffairsIL,

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

Posted Mar 13, 2026

36E79726R0009

Closed

Awarded1

6505--Hydralazine HCL Injections Award - Hikma Pharmaceuticals

The Department of Veterans Affairs National Acquisition Center awarded contract 36E79726D0001 to Hikma Pharmaceuticals USA Inc. on November 21, 2025, for the procurement of Hydralazine HCL Injections. The total award amount is $2,371,481.00. This procurement falls under NAICS code 325412 for Pharmaceutical Preparation Manufacturing and Product Service Code 6505. The contract was managed by Contracting Officer Nicholas McGregor out of the Hines, Illinois office. Hikma Pharmaceuticals USA Inc., located in Berkeley Heights, New Jersey, is the primary awardee. While the award notice confirms the financial value and the specific pharmaceutical product, detailed technical specifications, delivery schedules, and specific FAR clauses were not provided in the available documentation.

Department Of Veterans AffairsIL, USA$2.4M est.

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

36E79725R0048

Awarded

Awarded1

6505--Clobetasol Cream and Ointment Encube Ethicals, Inc. Base Ordering Period 11/17/2025 - 11/16/2026

This contract pertains to the procurement of Clobetasol Cream and Ointment, identified by the solicitation number 36E79725R0040, issued by Nac Pharmaceuticals, an organization based in Hines, Illinois. The contract was posted on May 22, 2025, with a response deadline set for June 10, 2025. The NAICS code associated with this procurement is 325412, indicating it falls within the pharmaceutical manufacturing sector. The contract is managed by a designated Contract Specialist, Ray Roldan, whose contact information is provided for inquiries. The procurement is intended to support the needs of the VA, with the opportunity details accessible via the provided link on SAM.gov. The specific scope of work, contract size, and place of performance details are not explicitly outlined in the available data.

Department Of Veterans AffairsIL, USA$6.3M est.

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

36E79725R0040

Awarded Sep 16, 2025

Awarded1

6505--Acyclovir Capsules

The Department of Veterans Affairs, specifically through the NAC Pharmaceuticals office, awarded a contract for Acyclovir Capsules under solicitation number 36E79725R0033. The award, titled "6505--Acyclovir Capsules," was posted on July 22, 2025, with an official award notice issued the same day. The contract has a total value of $3,172,038.20 and was awarded to Golden State Medical Supply, Inc., headquartered in Camarillo, California. The NAICS code associated with this procurement is 325412, which pertains to Pharmaceutical Preparation Manufacturing. The point of contact for this contract is Andrew J. Cazares, Contracting Officer, who can be reached at [phone hidden] or via email at [email hidden]. While the place of performance is not specified, the awarding office is located in Hines, Illinois. The awarded contract number is 36E79725D0049, and the public can view more details about the opportunity through the provided online link. The contract remains active and is set to be archived on September 20, 2025.

Department Of Veterans AffairsIL, USA$3.2M est.

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

36E79725R0033

Awarded Jul 22, 2025

Awarded1

6505--Loperamide Capsules - GSMS

This contract involves the procurement of Loperamide Hydrochloride (HCL) 2mg capsules for the Department of Veterans Affairs, with a solicitation posted under number 36E79725R0025. The award will be made in the aggregate for specific line items, requiring offerors to submit pricing for a base year plus four additional one-year options, with prices to be listed to two decimal places and inclusive of a 0.5% Cost Recovery Fee. The contract emphasizes the importance of providing a unique 11-digit NDC number for each drug offered, whether from a manufacturer or distributor, to ensure proper identification. The solicitation is open until April 23, 2025, at 7:30 PM CT, and the contract is administered from the VA’s National Acquisition Center in Hines, Illinois. The process incorporates standard FAR clauses, including FAR 52.212-1 and FAR 52.212-4, with additional terms specified in attachments. The contract aims to establish a reliable supply of the specified pharmaceutical product, with detailed instructions for submission, pricing, and compliance outlined for potential offerors.

Department Of Veterans AffairsIL, USA$7.8M est.

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

36E79725R0025

Awarded Jul 7, 2025

Awarded1

6505--Ranolazine SA Tablets - Radha - 11/20/25 - 11/19/26

The contract is an award notice from the Department of Veterans Affairs, specifically under the NAC Pharmaceuticals sector, for the supply of Ranolazine SA Tablets. The contract was awarded to RADHA PHARMACEUTICALS INC, based in Hauppauge, New York, under award number 36E79725D0043. The contract period runs from November 20, 2025, to November 19, 2026, with a total value of $11,667,090.00. This award falls under NAICS code 325412, which covers pharmaceutical preparation manufacturing, and the federal classification code is 6505, denoting drugs and biologicals. The main point of contact for this contract is Deb Fassl, a Contract Specialist for the Department of Veterans Affairs, who can be reached at [email hidden] or by phone at [phone hidden]. The office managing this contract is located in Hines, Illinois. Although there is no specific information provided about the type of set-aside or place of performance, the award is currently listed as active and is set to be archived in August 2025. Further details about the contract and its documentation can be accessed through the provided links.

Department Of Veterans AffairsIL, USA$11.7M est.

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

36E79725R0036

Awarded Jun 26, 2025

Awarded1

6505--Fludrocortisone Acetate 0.1MG Tablets

The Department of Veterans Affairs National Acquisition Center has awarded a contract for Fludrocortisone Acetate 0.1MG Tablets, under solicitation number 36E79725R0023. The award, valued at $3,083,129.35, was granted on June 9, 2025, to Golden State Medical Supply, Inc., a company located in Camarillo, California. The contract carries the award number 36E79725D0041 and is classified under NAICS code 325412, which covers pharmaceutical preparation manufacturing, as well as Federal Supply Classification code 6505 for drugs and biologicals. This is an Award Notice type contract, issued by the Department of Veterans Affairs Pharmaceutical division, and remains active as of the notice date. The primary point of contact for this agreement is Youlanda Duggar, serving as Contract Specialist. The office responsible for managing the contract is located in Hines, Illinois. The contract supports ongoing pharmaceutical supply needs for the Department of Veterans Affairs, ensuring the continued provision of Fludrocortisone Acetate for its healthcare network. Further details and official documentation are accessible via the SAM.gov portal.

Department Of Veterans AffairsIL, USA$3.1M est.

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

36E79725R0023

Awarded Jun 9, 2025

Awarded2

6505--Short-Term Contract Prasugrel HCL Tablets Golden State Medical Supply, Inc.

The Department of Veterans Affairs, through Nac Pharmaceuticals, has issued a short-term, sole-source contract award to Golden State Medical Supply, Inc. for the procurement of Prasugrel HCL 5mg and 10mg tablets. This action, identified by solicitation number 36E79725R0044 and award number 36E79725D0035, was executed under FAR 6.302-2 due to unusual and compelling urgency. The primary objective of this agreement is to maintain an uninterrupted supply of critical medication for the VA and other federal agencies while a protest concerning the primary contract is being adjudicated. The contract has a total estimated value of 203,777.12 dollars and covers an initial three-month period with an additional two-month option. The award was finalized on May 8, 2025, and falls under NAICS code 325412. Administrative oversight for this procurement is managed by Contracting Officer Nicholas McGregor out of the Hines, Illinois office.

Department Of Veterans AffairsIL, USA$204K est.

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

36E79725R0044

Awarded May 8, 2025